Alnylam Pharmaceuticals Inc (DUL)
Market Closed
17 Jul, 20:00
€
233. 00
-14.3
-5.7825%
€
- Market Cap
- P/E Ratio
- Div Yield
705 Volume
-3.56 Eps
€ 247.3
Previous Close Want to track DUL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alnylam Pharmaceuticals Inc (DUL) Statistics
Valuation metrics
Market Cap -
Enterprise value 35.27B
Trailing P/E (ttm) 61.35
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 8.33
Price/Book (mrq) 33.05
Enterprise Value/Revenue 8.23
Enterprise Value/EBITDA 38.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 215
Average volume (90 days) 40
Price summary
52-Week low 233
52-Week high 423
Beta -
50-Day moving average 257.25
200-Day moving average 273.89
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.98%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 32.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 22.64
Total debt (mrq) -
Total Debt/Equity (mrq) 1.18
Current ratio (mrq) 3.13%
Book value per share (mrq) 8.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
